AFP and hepatocellular carcinoma: Although AFP or PIVKA-II alone was not potent enough for detecting early-stage HCC, the combination of AFP, AFP-L3 and PIVKA-II increased the detection sensitivity and was suggested to be effective in HCC screening [52–54].